Karyopharm to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Karyopharm (Nasdaq: KPTI) announced that senior management will participate in two May 2026 investor conferences via fireside chats: the H.C. Wainwright 4th Annual BioConnect Investor Conference and the RBC 2026 Global Healthcare Conference, both on May 19, 2026.

Live webcasts and replays will be available in the Events & Presentations section of Karyopharm's investor relations website.

News Market Reaction – KPTI

+1.19%

2 alerts

+1.19% Session close to close

$208.60M Market Cap

0.0x Rel. Volume

In the May 12 session, KPTI gained 1.19%, reflecting a mild positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEWTON, Mass., May 12, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences in May:

H.C. Wainwright 4th Annual BioConnect Investor Conference
Format: Fireside chat
Date: Tuesday, May 19, 2026
Time: 9:00 a.m. ET

RBC 2026 Global Healthcare Conference
Format: Fireside chat
Date: Tuesday, May 19, 2026
Time: 3:35 p.m. ET

A live webcast of the fireside chats can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay following the event.

About Karyopharm Therapeutics

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO^® (selinexor), is approved in the U.S. and marketed by the Company in two oncology indications. It has also received regulatory approvals in various indications in more than 50 ex-U.S. territories and countries, including the European Union, the United Kingdom (as NEXPOVIO^®) and China. Karyopharm has a focused pipeline targeting indications in multiple high unmet need cancers, including in multiple myeloma, endometrial cancer, and myelofibrosis. For more information about our people, science and pipeline, please visit www.karyopharm.com, and follow us on LinkedIn and on X at @Karyopharm.

XPOVIO^® and NEXPOVIO^® are registered trademarks of Karyopharm Therapeutics Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-participate-at-upcoming-investor-conferences-302768660.html

SOURCE Karyopharm Therapeutics Inc.

FAQ

When will Karyopharm (KPTI) present at the H.C. Wainwright BioConnect Investor Conference in May 2026?

Karyopharm will hold a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference on Tuesday, May 19, 2026, at 9:00 a.m. ET. According to Karyopharm, investors can access the live webcast via its investor relations website.

What time is Karyopharm's (KPTI) fireside chat at the RBC 2026 Global Healthcare Conference?

Karyopharm's senior management will participate in a fireside chat at the RBC 2026 Global Healthcare Conference on Tuesday, May 19, 2026, at 3:35 p.m. ET. According to Karyopharm, the session will be webcast live for investors.

How can investors access the Karyopharm (KPTI) investor conference webcasts on May 19, 2026?

Investors can access live webcasts of both Karyopharm fireside chats through the Events & Presentations section of its investor website. According to Karyopharm, replays will also be posted online after the events conclude.

Will replays of Karyopharm's (KPTI) May 2026 investor conference fireside chats be available?

Yes, replays of Karyopharm's May 19, 2026 fireside chats will be available on the company's investor relations website. According to Karyopharm, they can be found under the Events & Presentations section following the live events.

What type of format will Karyopharm (KPTI) use at the May 2026 investor conferences?

Karyopharm will participate in both investor conferences using a fireside chat format with senior management on May 19, 2026. According to Karyopharm, each session will be webcast live and later archived for replay.